Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

A structure-based approach to a synthetic vaccine for HIV-1.

Cabezas E, Wang M, Parren PW, Stanfield RL, Satterthwait AC.

Biochemistry. 2000 Nov 28;39(47):14377-91.

PMID:
11087390
2.

Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine.

Sirois S, Touaibia M, Chou KC, Roy R.

Curr Med Chem. 2007;14(30):3232-42. Review.

PMID:
18220757
3.

Structural studies of human HIV-1 V3 antibodies.

Stanfield RL, Wilson IA.

Hum Antibodies. 2005;14(3-4):73-80. Review.

PMID:
16720977
4.

NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity.

Sharon M, Rosen O, Anglister J.

Curr Opin Drug Discov Devel. 2005 Sep;8(5):601-12. Review.

PMID:
16159022
5.

Conformational restriction of peptidyl immunogens with covalent replacements for the hydrogen bond.

Satterthwait AC, Arrhenius T, Hagopian RA, Zavala F, Nussenzweig V, Lerner RA.

Vaccine. 1988 Apr;6(2):99-103. Review.

PMID:
3291460
6.

Limitations to the structure-based design of HIV-1 vaccine immunogens.

Van Regenmortel MH.

J Mol Recognit. 2011 Sep-Oct;24(5):741-53. doi: 10.1002/jmr.1116. Review.

PMID:
21812050
7.

The conformational restriction of synthetic vaccines for malaria.

Satterthwait AC, Chiang LC, Arrhenius T, Cabezas E, Zavala F, Dyson HJ, Wright PE, Lerner RA.

Bull World Health Organ. 1990;68 Suppl:17-25. Review.

8.

Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-I retroviral infections.

Hart MK, Palker TJ, Haynes BF.

Pharm Biotechnol. 1995;6:821-45. Review. No abstract available.

PMID:
7551251
9.

Chemical Platforms for Peptide Vaccine Constructs.

Ramesh S, Cherkupally P, Govender T, Kruger HG, Albericio F, de la Torre BG.

Adv Protein Chem Struct Biol. 2015;99:99-130. doi: 10.1016/bs.apcsb.2015.03.005. Epub 2015 Apr 27. Review.

PMID:
26067818
11.

The use of peptides to reconstruct conformational determinants; a brief review.

Meloen RH, Amerongen AV, Hage-Van Noort M, Langedijk JP, Posthumus WP, Puyk WC, Plasman H, Lenstra JA, Langeveld JP.

Ann Biol Clin (Paris). 1991;49(4):231-41. Review.

PMID:
1928839
12.

Using synthetic peptide reagents to distinguish infections caused by different HIV strains.

Gnann JW Jr, Oldstone MB.

Curr Top Microbiol Immunol. 1990;160:131-43. Review. No abstract available.

PMID:
2191839

Supplemental Content

Support Center